High-performance liquid chromatographic bioanalysis of anthracycline cytostatic drugs. 1988

J H Beijnen, and W J Underberg
Slotervaart Hospital/Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands.

In the past decade high-performance liquid chromatography (HPLC) has developed into the most powerful tool available for the analysis of anthracycline antitumour drugs in all kinds of biological matrices. The results of drug level monitoring studies have contributed significantly to a better understanding of the pharmacokinetics and metabolic disposition of these drugs. Some aspects of anthracycline HPLC analysis in plasma samples are discussed, including the chromatographic separation and detection, sampling procedures, storage of plasma samples and sample pre-treatment.

UI MeSH Term Description Entries

Related Publications

J H Beijnen, and W J Underberg
January 1984, Annales pharmaceutiques francaises,
J H Beijnen, and W J Underberg
January 1983, Journal of chromatography,
J H Beijnen, and W J Underberg
January 2022, ADMET & DMPK,
J H Beijnen, and W J Underberg
December 1996, Forensic science review,
J H Beijnen, and W J Underberg
May 1997, Journal of chromatography. B, Biomedical sciences and applications,
J H Beijnen, and W J Underberg
August 1995, Journal of chromatography. B, Biomedical applications,
J H Beijnen, and W J Underberg
March 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
J H Beijnen, and W J Underberg
September 1975, Journal of pharmaceutical sciences,
Copied contents to your clipboard!